Ryman Healthcare Ltd
NZX:RYM
Ryman Healthcare Ltd
Ryman Healthcare Ltd., a titan in the world of retirement living and aged care, began its journey in 1984 with an ambitious vision to redefine what retirement living could be. Based in Christchurch, New Zealand, the company has artfully crafted a unique model that integrates independent living, assisted living, and residential care services under one roof. This model allows residents the comfort of aging in place, seamlessly transitioning between different levels of care as their needs evolve. It’s a vertically integrated business that not only designs and constructs its villages, thus maintaining rigorous quality standards, but also manages and operates them, ensuring a consistent and reliable level of service. By retaining real estate ownership and operations, Ryman creates a sustainable revenue stream and builds equity over time, distinguishing itself from competitors in this ever-growing sector.
Financially, the company thrives on a dual-income strategy focusing on both the initial sale of occupancy rights and recurring fees. When a resident purchases the right to occupy a unit, Ryman collects a deferred management fee, typically a significant percentage of the unit's price over several years of occupancy. In addition, ongoing service fees provide a steady income stream, covering a range of amenities and services from healthcare to community activities, which are meticulously designed to enrich residents' quality of life. This financial structure not only secures Ryman’s operational cash flow but also reinforces its commitment to long-term sustainability. Coupled with strategic expansions into the Australian market, Ryman Healthcare is effectively capitalizing on demographic trends, notably an aging population, while adhering to a compassionate, customer-centric approach that sets it apart in the retirement living industry.
Ryman Healthcare Ltd., a titan in the world of retirement living and aged care, began its journey in 1984 with an ambitious vision to redefine what retirement living could be. Based in Christchurch, New Zealand, the company has artfully crafted a unique model that integrates independent living, assisted living, and residential care services under one roof. This model allows residents the comfort of aging in place, seamlessly transitioning between different levels of care as their needs evolve. It’s a vertically integrated business that not only designs and constructs its villages, thus maintaining rigorous quality standards, but also manages and operates them, ensuring a consistent and reliable level of service. By retaining real estate ownership and operations, Ryman creates a sustainable revenue stream and builds equity over time, distinguishing itself from competitors in this ever-growing sector.
Financially, the company thrives on a dual-income strategy focusing on both the initial sale of occupancy rights and recurring fees. When a resident purchases the right to occupy a unit, Ryman collects a deferred management fee, typically a significant percentage of the unit's price over several years of occupancy. In addition, ongoing service fees provide a steady income stream, covering a range of amenities and services from healthcare to community activities, which are meticulously designed to enrich residents' quality of life. This financial structure not only secures Ryman’s operational cash flow but also reinforces its commitment to long-term sustainability. Coupled with strategic expansions into the Australian market, Ryman Healthcare is effectively capitalizing on demographic trends, notably an aging population, while adhering to a compassionate, customer-centric approach that sets it apart in the retirement living industry.
Underlying Profit: Ryman delivered underlying profit of $301.9 million, up 18.4% year-on-year and ahead of prior guidance.
IFRS Profit Drop: Reported profit fell 62.8% to $257.8 million due to lower revaluation gains and costs from early debt repayment.
Australian Strength: The Australian business saw strong growth, with underlying profit up 36.1% and higher margins than expected.
Equity Raise & Deleveraging: A $902.4 million equity raise reduced net debt and gearing, strengthening the balance sheet.
No Final Dividend: No final FY 2023 dividend; Board will consider resuming dividends in FY 2024 depending on performance.
Development Delays: Severe weather events delayed construction, resulting in fewer delivered units and beds than targeted.
FY 2024 Guidance: Underlying profit guidance for FY 2024 set at $310–330 million; portfolio expected to grow by 750–800 units/beds.
Cash Flow Focus: Free cash outflow for FY 2023 was $389 million, with a target for positive free cash flow by FY 2025.
